Skip to main content
. 2022 Jul 7;11(14):2136. doi: 10.3390/cells11142136

Figure 3.

Figure 3

Tunicamycin inhibits epithelial-to-mesenchymal transition in human CRC cell lines. SW480 and HCT116 cells were exposed to tunicamycin (0.1 μg/mL, 0.5 μg/mL). (A) Wound healing test revealed that tunicamycin inhibited HCT116 and SW480 cell migration. (BD) SW480 and HCT116 cells were exposed to tunicamycin (0.1 μg/mL, 0.5 μg/mL) for 6 h, and then analyzed for protein and mRNA expression. qRT-PCR and Western blotting results showed the expression of proteins and mRNA involved in EMT.